COLESTIPOL HYDROCHLORIDE

COLESTIPOL HYDROCHLORIDE was reported 2658 times

COLESTIPOL HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INFUSION SITE STREAKING 10 0.1149
1 PRODUCT FRIABLE 8 0.0708
2 ANAL SKIN TAGS 10 0.0606
3 ALLERGY TO SURGICAL SUTURES 2 0.0465
4 VAGINAL ABSCESS 10 0.0368
5 PERINEPHRIC ABSCESS 5 0.0329
6 FEEDING INTOLERANCE 12 0.0266
7 BILIARY DRAINAGE 2 0.0192
8 RECTAL FISSURE 11 0.0175
9 VITAMIN D INCREASED 10 0.0162
10 INTESTINAL ANASTOMOSIS COMPLICATION 4 0.0148
11 PROCEDURAL ANXIETY 10 0.0147
12 LARGE INTESTINAL ULCER 32 0.0118
13 DUMPING SYNDROME 3 0.0114
14 GASTROINTESTINAL MICROORGANISM OVERGROWTH 3 0.0085
15 PSOAS ABSCESS 4 0.0064
16 CHOLANGITIS SCLEROSING 13 0.0063
17 FEMALE GENITAL TRACT FISTULA 10 0.0059
18 COLONIC STENOSIS 2 0.0058
19 DENTAL RESTORATION FAILURE 4 0.0055
20 LACTOSE INTOLERANCE 14 0.0055
21 GASTROINTESTINAL ULCER 12 0.0054
22 PRODUCT SIZE ISSUE 29 0.0054
23 HAEMATOCRIT INCREASED 12 0.0053
24 SERUM FERRITIN DECREASED 9 0.0052
25 FOREIGN BODY IN THROAT 15 0.0048
26 SMALL INTESTINE ULCER 3 0.0046
27 PRODUCT PHYSICAL ISSUE 89 0.0044
28 BLOOD CHROMOGRANIN A INCREASED 2 0.0044
29 INTESTINAL FISTULA 6 0.0043
30 ELECTROCARDIOGRAM ST-T CHANGE 3 0.0042
31 PROTEUS INFECTION 3 0.0042
32 LIPIDS ABNORMAL 3 0.0041
33 THROMBOTIC STROKE 3 0.0041
34 OESOPHAGEAL DISCOMFORT 3 0.0040
35 ILEAL ULCER 4 0.0040
36 MONOCLONAL IMMUNOGLOBULIN PRESENT 3 0.0039
37 FAECAL VOLUME INCREASED 2 0.0038
38 THERAPEUTIC REACTION TIME DECREASED 11 0.0038
39 WHITE BLOOD CELL DISORDER 10 0.0037
40 PRODUCT USE COMPLAINT 58 0.0037
41 ABSCESS ORAL 5 0.0036
42 OESOPHAGEAL ULCER 14 0.0036
43 MUCOUS STOOLS 18 0.0036
44 PERITONSILLAR ABSCESS 3 0.0036
45 VEIN RUPTURE 6 0.0036
46 BLOOD CHLORIDE DECREASED 9 0.0035
47 CELLULITIS ORBITAL 2 0.0034
48 AXIAL SPONDYLOARTHRITIS 3 0.0034
49 ALLERGY TO METALS 2 0.0033
50 ENTEROCOLITIS INFECTIOUS 3 0.0033
51 ABSCESS INTESTINAL 7 0.0032
52 ELBOW OPERATION 2 0.0032
53 DERMATITIS EXFOLIATIVE GENERALISED 11 0.0032
54 RED BLOOD CELL ABNORMALITY 3 0.0031
55 OESOPHAGEAL PAIN 12 0.0030
56 INTESTINAL RESECTION 16 0.0030
57 STOMA COMPLICATION 3 0.0030
58 PRODUCT DIFFICULT TO SWALLOW 3 0.0030
59 POOR QUALITY PRODUCT ADMINISTERED 31 0.0029
60 PRODUCT COATING ISSUE 3 0.0029
61 DRUG SPECIFIC ANTIBODY 4 0.0029
62 HAEMOGLOBIN INCREASED 13 0.0028
63 BUNION 2 0.0028
64 FISTULA 29 0.0026
65 DEFAECATION URGENCY 18 0.0026
66 EXTRADURAL ABSCESS 2 0.0025
67 CROUP INFECTIOUS 2 0.0025
68 BARRETT'S OESOPHAGUS 2 0.0025
69 ORAL INTAKE REDUCED 6 0.0025
70 STAPHYLOCOCCAL SKIN INFECTION 3 0.0024
71 DIVERTICULUM 17 0.0024
72 INTESTINAL STENOSIS 10 0.0024
73 FRACTURED COCCYX 3 0.0024
74 VAGINAL INFECTION 11 0.0023
75 PROTEIN TOTAL ABNORMAL 3 0.0023
76 WEIGHT FLUCTUATION 24 0.0023
77 SPLENIC INFARCTION 4 0.0023
78 FOREIGN BODY IN RESPIRATORY TRACT 3 0.0023
79 INFUSION SITE DISCHARGE 4 0.0023
80 ANORECTAL DISCOMFORT 12 0.0023
81 INTESTINAL DILATATION 3 0.0022
82 URETERIC OBSTRUCTION 3 0.0022
83 DRUG LEVEL ABOVE THERAPEUTIC 10 0.0022
84 ADVERSE FOOD REACTION 2 0.0021
85 COR PULMONALE 2 0.0021
86 BLADDER CATHETERISATION 2 0.0021
87 NASAL SEPTUM DEVIATION 4 0.0020
88 GINGIVAL SWELLING 9 0.0020
89 CYSTIC FIBROSIS 11 0.0020
90 URINARY TRACT INFECTION BACTERIAL 5 0.0020
91 GENITAL HERPES 3 0.0020
92 ILEOSTOMY 5 0.0020
93 NEUTROPENIC COLITIS 4 0.0019
94 CROHN'S DISEASE 13 0.0019
95 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 2 0.0019
96 PROCTALGIA 12 0.0019
97 CHOKING 36 0.0018
98 BLADDER DILATATION 2 0.0018
99 SPINAL CORD DISORDER 3 0.0018
100 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 3 0.0018
101 BILIARY DYSKINESIA 3 0.0018
102 ENTERITIS INFECTIOUS 3 0.0018
103 UTERINE DISORDER 4 0.0017
104 ILEAL STENOSIS 3 0.0017
105 FOOD ALLERGY 13 0.0017
106 ANAL FISSURE 9 0.0017
107 DYSFUNCTIONAL UTERINE BLEEDING 2 0.0016
108 BLOOD IMMUNOGLOBULIN G INCREASED 2 0.0016
109 OESOPHAGEAL SPASM 3 0.0016
110 NERVE COMPRESSION 15 0.0016
111 BLOOD UREA DECREASED 2 0.0016
112 FAECAL CALPROTECTIN INCREASED 5 0.0016
113 C-REACTIVE PROTEIN ABNORMAL 10 0.0016
114 FREQUENT BOWEL MOVEMENTS 42 0.0016
115 APGAR SCORE LOW 2 0.0016
116 FEAR OF INJECTION 11 0.0015
117 ABDOMINAL OPERATION 2 0.0015
118 ACROCHORDON 2 0.0015
119 GINGIVAL PAIN 12 0.0015
120 CHOLECYSTITIS CHRONIC 10 0.0015
121 VITAMIN B12 DEFICIENCY 6 0.0015
122 FRACTURE NONUNION 2 0.0015
123 INFUSION SITE SWELLING 9 0.0014
124 ERYTHEMA NODOSUM 5 0.0014
125 INCONTINENCE 15 0.0014
126 ANEURYSM 7 0.0014
127 SHOULDER OPERATION 6 0.0014
128 IRRITABLE BOWEL SYNDROME 30 0.0014
129 INFUSION SITE BRUISING 3 0.0014
130 SMALL INTESTINAL OBSTRUCTION 17 0.0014
131 COLONOSCOPY 3 0.0014
132 GASTRIC POLYPS 3 0.0013
133 INTESTINAL OBSTRUCTION 50 0.0013
134 EPICONDYLITIS 2 0.0013
135 RESPIRATORY TRACT CONGESTION 21 0.0013
136 REACTION TO EXCIPIENT 3 0.0013
137 BACTERIAL VAGINOSIS 2 0.0013
138 BLOOD MAGNESIUM DECREASED 11 0.0013
139 PRODUCT ADMINISTRATION INTERRUPTED 10 0.0013
140 PANCREATITIS CHRONIC 3 0.0013
141 COLITIS MICROSCOPIC 6 0.0013
142 ABDOMINAL ADHESIONS 4 0.0013
143 LOSS OF THERAPEUTIC RESPONSE 4 0.0013
144 AORTIC VALVE DISEASE 2 0.0012
145 COLECTOMY 7 0.0012
146 HAEMORRHOIDS 24 0.0012
147 BODY TEMPERATURE DECREASED 12 0.0012
148 DEVICE INFUSION ISSUE 3 0.0012
149 HYPERPARATHYROIDISM SECONDARY 3 0.0012
150 CLOSTRIDIUM DIFFICILE INFECTION 26 0.0012
151 CEREBELLAR INFARCTION 2 0.0012
152 EROSIVE OESOPHAGITIS 2 0.0012
153 DEAFNESS BILATERAL 2 0.0012
154 CERVICAL SPINAL STENOSIS 2 0.0012
155 ACUTE SINUSITIS 2 0.0012
156 MALABSORPTION 6 0.0011
157 SPINAL OSTEOARTHRITIS 10 0.0011
158 CHOLECYSTECTOMY 13 0.0011
159 ABDOMINAL ABSCESS 5 0.0011
160 MYCOBACTERIUM AVIUM COMPLEX INFECTION 3 0.0011
161 INJECTION SITE DISCHARGE 6 0.0011
162 IRON DEFICIENCY 5 0.0011
163 ESSENTIAL HYPERTENSION 2 0.0011
164 RED BLOOD CELL SEDIMENTATION RATE INCREASED 12 0.0011
165 BLOOD PRESSURE DIASTOLIC DECREASED 8 0.0011
166 NEPHROGENIC ANAEMIA 5 0.0011
167 SERUM SICKNESS 3 0.0011
168 CHRONIC SINUSITIS 4 0.0011
169 PROTEIN TOTAL DECREASED 4 0.0011
170 SEASONAL ALLERGY 15 0.0011
171 SUBCUTANEOUS ABSCESS 5 0.0010
172 VITAMIN B12 DECREASED 3 0.0010
173 APHTHOUS ULCER 8 0.0010
174 EARLY SATIETY 2 0.0010
175 PULMONARY PAIN 3 0.0010
176 ABNORMAL LOSS OF WEIGHT 7 0.0010
177 VULVOVAGINAL MYCOTIC INFECTION 4 0.0010
178 ODYNOPHAGIA 6 0.0010
179 ABSCESS 16 0.0010
180 FOREIGN BODY 4 0.0010
181 CANDIDIASIS 4 0.0010
182 PRODUCT SOLUBILITY ABNORMAL 5 0.0010
183 EAR HAEMORRHAGE 2 0.0010
184 EYELID PAIN 2 0.0010
185 POST PROCEDURAL INFECTION 8 0.0010
186 BLOOD CALCIUM DECREASED 11 0.0010
187 DIASTOLIC DYSFUNCTION 3 0.0010
188 PRODUCT DISTRIBUTION ISSUE 9 0.0010
189 PHARYNGITIS 12 0.0010
190 POOR VENOUS ACCESS 10 0.0010
191 ATRIAL TACHYCARDIA 2 0.0010
192 POOR PERIPHERAL CIRCULATION 4 0.0009
193 INCOHERENT 6 0.0009
194 GASTROINTESTINAL PAIN 10 0.0009
195 CLOSTRIDIUM TEST POSITIVE 2 0.0009
196 CALCINOSIS 2 0.0009
197 FURUNCLE 7 0.0009
198 DIABETIC RETINOPATHY 3 0.0009
199 COMPUTERISED TOMOGRAM ABNORMAL 2 0.0009
200 VASCULAR DEVICE INFECTION 4 0.0009
201 WOUND COMPLICATION 3 0.0009
202 BLOOD PRESSURE SYSTOLIC INCREASED 17 0.0009
203 SKIN ATROPHY 5 0.0009
204 ENTEROCOLITIS 5 0.0009
205 INTERVERTEBRAL DISC DEGENERATION 8 0.0009
206 AORTIC STENOSIS 3 0.0009
207 DEVICE FAILURE 13 0.0009
208 HIATUS HERNIA 11 0.0008
209 BLOOD TRIGLYCERIDES INCREASED 15 0.0008
210 FIBRIN D DIMER INCREASED 3 0.0008
211 CHRONIC LYMPHOCYTIC LEUKAEMIA 4 0.0008
212 APPENDICECTOMY 3 0.0008
213 PYODERMA GANGRENOSUM 3 0.0008
214 OESOPHAGITIS 9 0.0008
215 EAR PAIN 16 0.0008
216 BRONCHITIS CHRONIC 2 0.0008
217 FLATULENCE 46 0.0008
218 GASTROINTESTINAL SOUNDS ABNORMAL 4 0.0008
219 NEPHROLITHIASIS 37 0.0008
220 PRE-EXISTING CONDITION IMPROVED 5 0.0008
221 INTENTIONAL PRODUCT USE ISSUE 70 0.0008
222 EYELID IRRITATION 2 0.0008
223 DERMATITIS CONTACT 9 0.0008
224 GALLBLADDER DISORDER 14 0.0008
225 CANCER PAIN 2 0.0008
226 PHLEBITIS 4 0.0008
227 ANAL INCONTINENCE 7 0.0008
228 INFUSION SITE PAIN 10 0.0008
229 SENSATION OF HEAVINESS 3 0.0008
230 FAECES HARD 3 0.0008
231 ACTINIC KERATOSIS 2 0.0008
232 PRODUCT ODOUR ABNORMAL 8 0.0008
233 BLOOD IRON DECREASED 9 0.0008
234 BLOOD ALBUMIN DECREASED 6 0.0008
235 APPETITE DISORDER 5 0.0008
236 OBSTRUCTION 3 0.0008
237 BLOOD CHOLESTEROL INCREASED 35 0.0008
238 BLOOD DISORDER 6 0.0007
239 ABDOMINAL MASS 2 0.0007
240 ORGAN FAILURE 3 0.0007
241 HEART RATE DECREASED 26 0.0007
242 PHARYNGITIS STREPTOCOCCAL 8 0.0007
243 SPINAL STENOSIS 3 0.0007
244 RECTAL HAEMORRHAGE 31 0.0007
245 SELF-INJURIOUS IDEATION 3 0.0007
246 COLITIS 27 0.0007
247 DRUG TOLERANCE DECREASED 2 0.0007
248 PERIORBITAL SWELLING 4 0.0007
249 HAEMATOCRIT DECREASED 14 0.0007
250 CHOLECYSTITIS ACUTE 4 0.0007
251 HAND FRACTURE 5 0.0007
252 NEUROLOGICAL SYMPTOM 4 0.0007
253 TENSION HEADACHE 3 0.0007
254 EMPHYSEMA 7 0.0007
255 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 38 0.0007
256 ATRIOVENTRICULAR BLOCK FIRST DEGREE 3 0.0007
257 HAEMATOCHEZIA 38 0.0007
258 FAECES SOFT 5 0.0007
259 ORAL CANDIDIASIS 9 0.0007
260 RHINITIS ALLERGIC 3 0.0007
261 HERNIA 13 0.0007
262 GASTROINTESTINAL INFECTION 6 0.0007
263 ATYPICAL PNEUMONIA 2 0.0007
264 BLOOD POTASSIUM DECREASED 20 0.0007
265 SUSPECTED OFF LABEL USE 3 0.0007
266 CENTRAL VENOUS CATHETERISATION 2 0.0007
267 CRANIOCEREBRAL INJURY 2 0.0007
268 CLOSTRIDIUM DIFFICILE COLITIS 7 0.0007
269 EAR DISORDER 3 0.0007
270 PNEUMONIA BACTERIAL 6 0.0007
271 ARTHRITIS INFECTIVE 3 0.0006
272 BRAIN FOG 10 0.0006
273 SKIN TIGHTNESS 3 0.0006
274 ARTHRITIS 50 0.0006
275 SKIN ABRASION 3 0.0006
276 PULSE ABSENT 3 0.0006
277 RENAL CYST 5 0.0006
278 PRODUCTIVE COUGH 30 0.0006
279 MALNUTRITION 7 0.0006
280 HUMERUS FRACTURE 3 0.0006
281 DYSPHAGIA 59 0.0006
282 ANTINUCLEAR ANTIBODY POSITIVE 2 0.0006
283 INFLAMMATORY BOWEL DISEASE 6 0.0006
284 POLYP 4 0.0006
285 ABNORMAL FAECES 5 0.0006
286 SYNOVITIS 11 0.0006
287 STAPHYLOCOCCAL SEPSIS 3 0.0006
288 DIABETIC NEUROPATHY 3 0.0006
289 THERAPEUTIC RESPONSE SHORTENED 20 0.0006
290 UPPER LIMB FRACTURE 12 0.0006
291 FLUID INTAKE REDUCED 3 0.0006
292 SKIN MASS 4 0.0006
293 ANXIETY DISORDER 2 0.0006
294 POST-TRAUMATIC STRESS DISORDER 4 0.0006
295 CLOSTRIDIAL INFECTION 2 0.0006
296 B-CELL LYMPHOMA 2 0.0006
297 DIARRHOEA 380 0.0006
298 AMMONIA INCREASED 3 0.0006
299 HYPERLIPIDAEMIA 7 0.0006
300 SINUSITIS 60 0.0006
301 VITAMIN D DECREASED 5 0.0006
302 DYSPNOEA EXERTIONAL 22 0.0006
303 BENIGN PROSTATIC HYPERPLASIA 3 0.0006
304 FIBROMYALGIA 14 0.0006
305 CAROTID ARTERY STENOSIS 2 0.0006
306 PHARYNGOLARYNGEAL PAIN 3 0.0006
307 ILLNESS 58 0.0006
308 ANAL ABSCESS 3 0.0006
309 FACIAL BONES FRACTURE 2 0.0006
310 THROAT TIGHTNESS 15 0.0006
311 CHEILITIS 3 0.0006
312 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 3 0.0006
313 EYE PAIN 31 0.0005
314 MAJOR DEPRESSION 4 0.0005
315 TOOTH FRACTURE 6 0.0005
316 CHOKING SENSATION 3 0.0005
317 DRUG LEVEL BELOW THERAPEUTIC 3 0.0005
318 PRODUCT PHYSICAL CONSISTENCY ISSUE 3 0.0005
319 TOOTH DISORDER 12 0.0005
320 STREPTOCOCCAL INFECTION 3 0.0005
321 PRODUCT LEAKAGE 3 0.0005
322 INTESTINAL PERFORATION 6 0.0005
323 HYDRONEPHROSIS 4 0.0005
324 LOWER RESPIRATORY TRACT INFECTION 24 0.0005
325 EAR INFECTION 14 0.0005
326 VISUAL DISTURBANCE 3 0.0005
327 BOWEL MOVEMENT IRREGULARITY 4 0.0005
328 SUPRAVENTRICULAR TACHYCARDIA 5 0.0005
329 NEOPLASM 6 0.0005
330 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 37 0.0005
331 HYPERCHOLESTEROLAEMIA 5 0.0005
332 LOW DENSITY LIPOPROTEIN INCREASED 4 0.0005
333 RALES 3 0.0005
334 RETCHING 11 0.0005
335 DIZZINESS POSTURAL 5 0.0005
336 VITAMIN D DEFICIENCY 5 0.0005
337 MULTIPLE ALLERGIES 4 0.0005
338 THERAPY CHANGE 5 0.0005
339 ENERGY INCREASED 3 0.0005
340 TRICUSPID VALVE INCOMPETENCE 4 0.0005
341 ENURESIS 2 0.0005
342 NOCTURIA 6 0.0005
343 SPINAL OPERATION 6 0.0005
344 BLOOD ALKALINE PHOSPHATASE INCREASED 12 0.0005
345 HEPATIC STEATOSIS 9 0.0005
346 MIDDLE INSOMNIA 9 0.0005
347 EYE DISCHARGE 5 0.0005
348 SKIN DISORDER 16 0.0005
349 NASAL DRYNESS 3 0.0005
350 ABDOMINAL PAIN LOWER 12 0.0005
351 INFUSION SITE ERYTHEMA 4 0.0005
352 DEHYDRATION 63 0.0005
353 BUNDLE BRANCH BLOCK LEFT 2 0.0005
354 INJECTION SITE IRRITATION 6 0.0005
355 ABDOMINAL DISTENSION 49 0.0005
356 ABSCESS LIMB 2 0.0005
357 JOINT INJURY 10 0.0005
358 DYSPEPSIA 46 0.0005
359 ABNORMAL SENSATION IN EYE 2 0.0005
360 DEVICE OPERATIONAL ISSUE 2 0.0005
361 LACRIMATION INCREASED 14 0.0005
362 MUSCLE STRAIN 4 0.0005
363 CARDIAC MURMUR 4 0.0005
364 MIGRAINE 44 0.0005
365 CHAPPED LIPS 2 0.0005
366 RESPIRATORY TRACT INFECTION 12 0.0005
367 BONE CANCER 2 0.0005
368 DIVERTICULUM INTESTINAL 2 0.0005
369 UPPER RESPIRATORY TRACT INFECTION 21 0.0005
370 CARDIAC FAILURE ACUTE 3 0.0004
371 THERAPY PARTIAL RESPONDER 7 0.0004
372 FACIAL PAIN 4 0.0004
373 DRUG-INDUCED LIVER INJURY 14 0.0004
374 GOUT 8 0.0004
375 SKIN INFECTION 5 0.0004
376 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 13 0.0004
377 EYE INFECTION 5 0.0004
378 UVEITIS 6 0.0004
379 TOOTHACHE 8 0.0004
380 MITRAL VALVE INCOMPETENCE 5 0.0004
381 BODY TEMPERATURE INCREASED 9 0.0004
382 ABDOMINAL HERNIA 2 0.0004
383 ECCHYMOSIS 3 0.0004
384 CORONARY ARTERY OCCLUSION 6 0.0004
385 INCREASED TENDENCY TO BRUISE 4 0.0004
386 UROSEPSIS 4 0.0004
387 PROCEDURAL PAIN 12 0.0004
388 PERSONALITY CHANGE 4 0.0004
389 ELECTROLYTE IMBALANCE 5 0.0004
390 EXTRASYSTOLES 3 0.0004
391 WOUND 12 0.0004
392 ABDOMINAL PAIN UPPER 88 0.0004
393 MOUTH ULCERATION 9 0.0004
394 SPLENOMEGALY 5 0.0004
395 FLANK PAIN 4 0.0004
396 BLOOD SODIUM DECREASED 8 0.0004
397 PRODUCT PACKAGING ISSUE 4 0.0004
398 EYE INFLAMMATION 4 0.0004
399 SLEEP APNOEA SYNDROME 8 0.0004
400 MACULAR DEGENERATION 5 0.0004
401 GASTRITIS 11 0.0004
402 SKIN CANCER 9 0.0004
403 WEIGHT DECREASED 116 0.0004
404 ENTEROCOCCAL INFECTION 2 0.0004
405 SINUS BRADYCARDIA 4 0.0004
406 INJECTION SITE HAEMATOMA 6 0.0004
407 ADRENAL INSUFFICIENCY 5 0.0004
408 HEAD INJURY 13 0.0004
409 ORAL HERPES 8 0.0004
410 ABDOMINAL PAIN 95 0.0004
411 HYPOPHOSPHATAEMIA 3 0.0004
412 HOSPICE CARE 4 0.0004
413 ARTHROPOD BITE 3 0.0004
414 LIGAMENT SPRAIN 4 0.0004
415 FOOT OPERATION 2 0.0004
416 SINUS DISORDER 8 0.0004
417 HEART RATE INCREASED 40 0.0004
418 CYST 5 0.0004
419 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 21 0.0004
420 SALIVARY HYPERSECRETION 4 0.0004
421 ABDOMINAL DISCOMFORT 67 0.0004
422 VAGINAL DISCHARGE 4 0.0004
423 TOOTH ABSCESS 4 0.0004
424 BRONCHITIS 29 0.0004
425 THIRST 7 0.0004
426 LIPASE INCREASED 3 0.0004
427 DRUG DELIVERY SYSTEM MALFUNCTION 2 0.0004
428 INITIAL INSOMNIA 4 0.0004
429 ROTATOR CUFF SYNDROME 5 0.0004
430 MUSCULOSKELETAL CHEST PAIN 6 0.0004
431 TEMPERATURE INTOLERANCE 4 0.0004
432 TENDONITIS 6 0.0004
433 FAILURE TO THRIVE 2 0.0004
434 VENTRICULAR EXTRASYSTOLES 4 0.0004
435 GASTROOESOPHAGEAL REFLUX DISEASE 31 0.0004
436 PULMONARY HYPERTENSION 8 0.0004
437 ELECTROCARDIOGRAM ABNORMAL 3 0.0004
438 RENAL PAIN 4 0.0004
439 RENAL FAILURE ACUTE 16 0.0004
440 INFLUENZA 42 0.0004
441 ATRIAL FLUTTER 3 0.0004
442 THINKING ABNORMAL 7 0.0004
443 SURGERY 22 0.0004
444 BLOOD PRESSURE FLUCTUATION 9 0.0004
445 ANAL FISTULA 2 0.0004
446 NASOPHARYNGITIS 69 0.0004
447 BODY HEIGHT DECREASED 4 0.0004
448 FOOD POISONING 2 0.0004
449 QUALITY OF LIFE DECREASED 5 0.0004
450 BREAST CANCER METASTATIC 4 0.0004
451 PHOTOPHOBIA 7 0.0004
452 SINUS CONGESTION 5 0.0004
453 BLOOD POTASSIUM INCREASED 6 0.0004
454 HYPOKALAEMIA 17 0.0004
455 SKIN LACERATION 4 0.0004
456 BLOOD PRESSURE INCREASED 56 0.0004
457 WOUND INFECTION 4 0.0004
458 FAECALOMA 2 0.0004
459 POST PROCEDURAL COMPLICATION 7 0.0004
460 PERIPHERAL COLDNESS 5 0.0004
461 UPPER-AIRWAY COUGH SYNDROME 3 0.0004
462 DEAFNESS UNILATERAL 2 0.0004
463 ORAL DISCOMFORT 5 0.0004
464 URINARY TRACT INFECTION 61 0.0004
465 THROAT IRRITATION 16 0.0004
466 INJURY 25 0.0004
467 CANDIDA INFECTION 6 0.0004
468 CHROMATURIA 8 0.0004
469 ACTIVITIES OF DAILY LIVING IMPAIRED 7 0.0004
470 DYSURIA 13 0.0004
471 MUSCULOSKELETAL DISCOMFORT 6 0.0003
472 SKIN ULCER 9 0.0003
473 IMPAIRED QUALITY OF LIFE 5 0.0003
474 BLOOD URIC ACID INCREASED 2 0.0003
475 POST PROCEDURAL HAEMORRHAGE 4 0.0003
476 NIGHT SWEATS 11 0.0003
477 OSTEOPOROSIS 14 0.0003
478 CONSTIPATION 74 0.0003
479 DECREASED INTEREST 2 0.0003
480 HEAD DISCOMFORT 6 0.0003
481 PULMONARY MASS 5 0.0003
482 COLON CANCER 5 0.0003
483 CARDIAC PACEMAKER INSERTION 2 0.0003
484 HAEMOLYTIC ANAEMIA 3 0.0003
485 GASTROENTERITIS VIRAL 6 0.0003
486 BLOOD PRESSURE DECREASED 22 0.0003
487 COVID-19 58 0.0003
488 END STAGE RENAL DISEASE 6 0.0003
489 OFF LABEL USE 288 0.0003
490 EATING DISORDER 7 0.0003
491 INFLUENZA LIKE ILLNESS 27 0.0003
492 DISCOMFORT 20 0.0003
493 INSURANCE ISSUE 5 0.0003
494 PRODUCT DOSE OMISSION ISSUE 96 0.0003
495 FEELING HOT 20 0.0003
496 CARDIOMEGALY 4 0.0003
497 PHARYNGEAL OEDEMA 5 0.0003
498 DIVERTICULITIS 9 0.0003
499 CHOLANGITIS 2 0.0003
500 ILEUS 4 0.0003
501 BASAL CELL CARCINOMA 5 0.0003
502 HEPATIC CIRRHOSIS 6 0.0003
503 ARTERIOSCLEROSIS 3 0.0003
504 SPINAL DISORDER 3 0.0003
505 FOOT FRACTURE 6 0.0003
506 SPUTUM DISCOLOURED 3 0.0003
507 FLUSHING 32 0.0003
508 ULCER 5 0.0003
509 ANGINA PECTORIS 9 0.0003
510 FOREIGN BODY SENSATION IN EYES 2 0.0003
511 RASH PRURITIC 17 0.0003
512 COLITIS ULCERATIVE 14 0.0003
513 SNEEZING 7 0.0003
514 ACUTE RESPIRATORY FAILURE 6 0.0003
515 ATELECTASIS 3 0.0003
516 ERUCTATION 6 0.0003
517 BACK PAIN 72 0.0003
518 HEART RATE IRREGULAR 7 0.0003
519 AUTOIMMUNE DISORDER 3 0.0003
520 DRUG SPECIFIC ANTIBODY PRESENT 2 0.0003
521 BACK DISORDER 5 0.0003
522 PLATELET COUNT INCREASED 4 0.0003
523 ASTHENIA 115 0.0003
524 KIDNEY INFECTION 6 0.0003
525 LABORATORY TEST ABNORMAL 9 0.0003
526 NEUROPATHY PERIPHERAL 29 0.0003
527 IMMUNE SYSTEM DISORDER 4 0.0003
528 DISABILITY 6 0.0003
529 PULMONARY CONGESTION 4 0.0003
530 CORONAVIRUS INFECTION 2 0.0003
531 BLADDER DISORDER 3 0.0003
532 INABILITY TO AFFORD MEDICATION 3 0.0003
533 DRY EYE 15 0.0003
534 VIRAL INFECTION 10 0.0003
535 OVARIAN CYST 3 0.0003
536 MUSCLE SPASMS 55 0.0003
537 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 54 0.0003
538 SPINAL FRACTURE 6 0.0003
539 CONDITION AGGRAVATED 91 0.0003
540 BREAST MASS 2 0.0003
541 FULL BLOOD COUNT DECREASED 6 0.0003
542 BRONCHIECTASIS 2 0.0003
543 COLITIS ISCHAEMIC 2 0.0003
544 HERPES ZOSTER 17 0.0003
545 VERTIGO 18 0.0003
546 DRUG LEVEL DECREASED 3 0.0003
547 NAUSEA 233 0.0003
548 PALLOR 8 0.0003
549 PRODUCT PREPARATION ERROR 6 0.0003
550 HELICOBACTER INFECTION 3 0.0003
551 LIMB DISCOMFORT 9 0.0003
552 PNEUMONIA 94 0.0003
553 ANAPHYLACTIC REACTION 16 0.0003
554 PRESYNCOPE 7 0.0003
555 POLLAKIURIA 12 0.0003
556 ATRIAL FIBRILLATION 28 0.0003
557 FORMICATION 2 0.0003
558 HUNGER 4 0.0003
559 ORTHOSTATIC HYPOTENSION 5 0.0003
560 ECZEMA 15 0.0003
561 NECK PAIN 16 0.0003
562 DEMENTIA 8 0.0003
563 CARPAL TUNNEL SYNDROME 4 0.0003
564 COUGH 80 0.0003
565 INJECTION SITE DISCOMFORT 3 0.0003
566 BURNING SENSATION 20 0.0003
567 FATIGUE 220 0.0003
568 PAIN IN JAW 8 0.0003
569 HYPOTHYROIDISM 9 0.0003
570 OROPHARYNGEAL PAIN 26 0.0003
571 DECREASED APPETITE 65 0.0003
572 SYNCOPE 28 0.0003
573 RED BLOOD CELL COUNT DECREASED 8 0.0003
574 OEDEMA PERIPHERAL 34 0.0003
575 HOT FLUSH 21 0.0003
576 WEIGHT INCREASED 62 0.0003
577 ARTHRALGIA 115 0.0003
578 FLUID RETENTION 14 0.0003
579 CHOLELITHIASIS 9 0.0003
580 HYPOTENSION 55 0.0003
581 DYSSTASIA 8 0.0003
582 OCULAR HYPERAEMIA 13 0.0003
583 VOMITING 128 0.0003
584 DENTAL CARIES 3 0.0003
585 BLINDNESS TRANSIENT 2 0.0003
586 DRY MOUTH 22 0.0003
587 CARDIOMYOPATHY 4 0.0003
588 URINARY INCONTINENCE 8 0.0003
589 NERVE INJURY 3 0.0003
590 FEELING DRUNK 2 0.0003
591 DRUG INTOLERANCE 26 0.0003
592 CATARACT 16 0.0003
593 EYE PRURITUS 9 0.0003
594 DEAFNESS 7 0.0003
595 TYPE 2 DIABETES MELLITUS 9 0.0003
596 CORONARY ARTERY DISEASE 8 0.0003
597 OSTEOPENIA 4 0.0003
598 CHRONIC KIDNEY DISEASE 20 0.0003
599 SCAB 3 0.0003
600 MICTURITION URGENCY 3 0.0003
601 ACIDOSIS 2 0.0003
602 DEEP VEIN THROMBOSIS 17 0.0003
603 ALANINE AMINOTRANSFERASE INCREASED 16 0.0003
604 EYE IRRITATION 15 0.0003
605 PRODUCT SUBSTITUTION ISSUE 15 0.0003
606 PERICARDIAL EFFUSION 6 0.0003
607 OSTEOARTHRITIS 11 0.0003
608 BLOOD BILIRUBIN INCREASED 7 0.0003
609 ANKLE FRACTURE 4 0.0003
610 FEMUR FRACTURE 8 0.0003
611 NERVOUS SYSTEM DISORDER 8 0.0003
612 PLASMA CELL MYELOMA 10 0.0003
613 TREATMENT NONCOMPLIANCE 14 0.0003
614 NASAL CONGESTION 15 0.0003
615 ARTERIAL OCCLUSIVE DISEASE 2 0.0003
616 PERIPHERAL SWELLING 39 0.0003
617 PNEUMOTHORAX 4 0.0003
618 CHOLECYSTITIS 3 0.0003
619 FEELING COLD 7 0.0003
620 HAEMOPTYSIS 7 0.0003
621 WRIST FRACTURE 3 0.0003
622 BLOOD GLUCOSE DECREASED 12 0.0002
623 CONTUSION 24 0.0002
624 THYROID CANCER 3 0.0002
625 DRUG EFFECT INCOMPLETE 9 0.0002
626 BURSITIS 3 0.0002
627 NEURALGIA 6 0.0002
628 DECUBITUS ULCER 2 0.0002
629 MUSCLE SPASTICITY 3 0.0002
630 CHEST DISCOMFORT 25 0.0002
631 HAEMOGLOBIN DECREASED 25 0.0002
632 EYE DISORDER 8 0.0002
633 STAPHYLOCOCCAL INFECTION 8 0.0002
634 PHOTOSENSITIVITY REACTION 4 0.0002
635 LOSS OF CONSCIOUSNESS 31 0.0002
636 DEPRESSION 55 0.0002
637 INJECTION SITE DISCOLOURATION 3 0.0002
638 WHITE BLOOD CELL COUNT DECREASED 26 0.0002
639 TINNITUS 11 0.0002
640 ROAD TRAFFIC ACCIDENT 10 0.0002
641 ASTHMA 27 0.0002
642 DERMATITIS 5 0.0002
643 PRODUCT USE IN UNAPPROVED INDICATION 59 0.0002
644 KNEE ARTHROPLASTY 5 0.0002
645 FALL 79 0.0002
646 PSYCHOTIC DISORDER 7 0.0002
647 HALLUCINATION, VISUAL 5 0.0002
648 DIABETES MELLITUS 18 0.0002
649 RENAL INJURY 7 0.0002
650 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 4 0.0002
651 ANXIETY 67 0.0002
652 HEPATIC ENZYME INCREASED 16 0.0002
653 HYPOPHAGIA 6 0.0002
654 RESPIRATORY DISORDER 7 0.0002
655 SCAR 4 0.0002
656 ANOREXIA 3 0.0002
657 MALAISE 102 0.0002
658 OXYGEN SATURATION DECREASED 13 0.0002
659 HEADACHE 145 0.0002
660 PHARMACEUTICAL PRODUCT COMPLAINT 6 0.0002
661 ANHEDONIA 6 0.0002
662 TOOTH INFECTION 3 0.0002
663 GASTROINTESTINAL HAEMORRHAGE 19 0.0002
664 VISION BLURRED 31 0.0002
665 FEELING ABNORMAL 54 0.0002
666 DIZZINESS 112 0.0002
667 THROMBOSIS 18 0.0002
668 JOINT RANGE OF MOTION DECREASED 3 0.0002
669 ORAL PAIN 5 0.0002
670 GASTROINTESTINAL DISORDER 20 0.0002
671 PARAESTHESIA 35 0.0002
672 THERAPY NON-RESPONDER 10 0.0002
673 LIMB INJURY 6 0.0002
674 TACHYPNOEA 3 0.0002
675 IMPAIRED GASTRIC EMPTYING 3 0.0002
676 CYSTITIS 7 0.0002
677 PRODUCT AVAILABILITY ISSUE 5 0.0002
678 BONE DISORDER 4 0.0002
679 EXOSTOSIS 2 0.0002
680 BLOOD THYROID STIMULATING HORMONE INCREASED 2 0.0002
681 HYPOMAGNESAEMIA 3 0.0002
682 COORDINATION ABNORMAL 3 0.0002
683 INFECTION 31 0.0002
684 DIARRHOEA HAEMORRHAGIC 2 0.0002
685 BLINDNESS UNILATERAL 3 0.0002
686 DYSARTHRIA 8 0.0002
687 RHEUMATOID ARTHRITIS 24 0.0002
688 HYPOCALCAEMIA 4 0.0002
689 MUSCULAR WEAKNESS 24 0.0002
690 GASTRIC ULCER 4 0.0002
691 FUNGAL INFECTION 7 0.0002
692 HYPERSOMNIA 6 0.0002
693 ACUTE KIDNEY INJURY 32 0.0002
694 HYPOACUSIS 9 0.0002
695 BALANCE DISORDER 18 0.0002
696 GLAUCOMA 4 0.0002
697 TRANSIENT ISCHAEMIC ATTACK 7 0.0002
698 JOINT SWELLING 25 0.0002
699 PAIN 127 0.0002
700 ERYTHEMA 42 0.0002
701 GASTRIC DISORDER 7 0.0002
702 RENAL FAILURE 27 0.0002
703 IMMUNODEFICIENCY 3 0.0002
704 RHINORRHOEA 13 0.0002
705 INJECTION SITE BRUISING 16 0.0002
706 EPISTAXIS 15 0.0002
707 CHEST PAIN 37 0.0002
708 PREGNANCY 4 0.0002
709 CARDIAC FAILURE CONGESTIVE 16 0.0002
710 APHASIA 6 0.0002
711 CELLULITIS 10 0.0002
712 ECONOMIC PROBLEM 3 0.0002
713 BLOOD COUNT ABNORMAL 3 0.0002
714 PRODUCT USE ISSUE 37 0.0002
715 EYELID PTOSIS 2 0.0002
716 DRY THROAT 2 0.0002
717 MEMORY IMPAIRMENT 27 0.0002
718 PALPITATIONS 23 0.0002
719 SKIN DISCOLOURATION 9 0.0002
720 DYSPNOEA 110 0.0002
721 MYALGIA 33 0.0002
722 UNRESPONSIVE TO STIMULI 5 0.0002
723 HYPERTENSION 41 0.0002
724 ALOPECIA 38 0.0002
725 RASH GENERALISED 5 0.0002
726 HAEMATOMA 5 0.0002
727 MENINGIOMA 3 0.0002
728 PANIC ATTACK 7 0.0002
729 LETHARGY 11 0.0002
730 ARRHYTHMIA 9 0.0002
731 SCIATICA 3 0.0002
732 DYSPHONIA 11 0.0002
733 PRURITUS 72 0.0002
734 IMPAIRED WORK ABILITY 4 0.0002
735 TREMOR 31 0.0002
736 DISTURBANCE IN ATTENTION 10 0.0002
737 DECREASED ACTIVITY 2 0.0002
738 INCORRECT PRODUCT ADMINISTRATION DURATION 4 0.0002
739 OEDEMA 10 0.0002
740 SLEEP DISORDER 13 0.0002
741 PRODUCT DISPENSING ERROR 4 0.0002
742 ANAEMIA 35 0.0002
743 INTERVERTEBRAL DISC PROTRUSION 4 0.0002
744 METASTASES TO BONE 3 0.0002
745 MUSCULOSKELETAL STIFFNESS 16 0.0002
746 VENTRICULAR TACHYCARDIA 3 0.0002
747 PLEURAL EFFUSION 11 0.0002
748 FOOT DEFORMITY 2 0.0002
749 LIP SWELLING 6 0.0002
750 SEPSIS 20 0.0002
751 CHILLS 21 0.0002
752 UPPER GASTROINTESTINAL HAEMORRHAGE 3 0.0002
753 THERAPEUTIC RESPONSE UNEXPECTED 8 0.0002
754 BLISTER 10 0.0002
755 FACE OEDEMA 3 0.0002
756 CIRCULATORY COLLAPSE 3 0.0002
757 INJECTION SITE PAIN 54 0.0002
758 INTENTIONAL DOSE OMISSION 5 0.0002
759 THERAPY CESSATION 9 0.0002
760 DELIRIUM 6 0.0002
761 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 35 0.0002
762 INSOMNIA 46 0.0002
763 DEVICE USE ISSUE 3 0.0002
764 COGNITIVE DISORDER 8 0.0002
765 CARDIAC DISORDER 16 0.0002
766 BONE PAIN 10 0.0002
767 ACUTE MYOCARDIAL INFARCTION 5 0.0002
768 LYMPHADENOPATHY 6 0.0002
769 DIABETES MELLITUS INADEQUATE CONTROL 3 0.0002
770 COVID-19 PNEUMONIA 2 0.0002
771 PLATELET COUNT DECREASED 18 0.0002
772 BACTERAEMIA 2 0.0002
773 THERAPY INTERRUPTED 12 0.0002
774 PYREXIA 58 0.0002
775 GAIT DISTURBANCE 32 0.0002
776 CONFUSIONAL STATE 27 0.0002
777 HEPATIC FAILURE 5 0.0002
778 FEBRILE NEUTROPENIA 11 0.0002
779 OSTEOMYELITIS 3 0.0002
780 LOCALISED INFECTION 4 0.0002
781 RESTLESS LEGS SYNDROME 3 0.0002
782 THERAPEUTIC RESPONSE DECREASED 10 0.0002
783 DRY SKIN 22 0.0002
784 RESTLESSNESS 6 0.0002
785 HYPERHIDROSIS 21 0.0002
786 HOSPITALISATION 25 0.0002
787 ABASIA 4 0.0002
788 EYE SWELLING 6 0.0002
789 SWELLING 15 0.0002
790 PAIN IN EXTREMITY 47 0.0002
791 FRACTURE 3 0.0002
792 BLOOD URINE PRESENT 3 0.0002
793 TACHYCARDIA 14 0.0002
794 CONVULSION 9 0.0002
795 PULMONARY FIBROSIS 3 0.0002
796 WHITE BLOOD CELL COUNT INCREASED 6 0.0002
797 PULMONARY OEDEMA 7 0.0002
798 RASH 68 0.0002
799 MOVEMENT DISORDER 5 0.0002
800 INFLAMMATION 8 0.0002
801 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 11 0.0002
802 DIPLOPIA 4 0.0002
803 SKIN FISSURES 3 0.0002
804 VISUAL IMPAIRMENT 19 0.0002
805 SEDATION 4 0.0002
806 IMPAIRED HEALING 5 0.0002
807 DEPRESSED MOOD 8 0.0002
808 BLOOD PRESSURE ABNORMAL 3 0.0002
809 RESPIRATORY FAILURE 11 0.0002
810 EYE HAEMORRHAGE 2 0.0001
811 URTICARIA 25 0.0001
812 PROSTATE CANCER 12 0.0001
813 MYOCARDIAL INFARCTION 26 0.0001
814 BLOOD GLUCOSE INCREASED 28 0.0001
815 PAIN OF SKIN 4 0.0001
816 PRODUCT ADMINISTRATION ERROR 3 0.0001
817 STOMATITIS 9 0.0001
818 DYSGEUSIA 11 0.0001
819 PULMONARY EMBOLISM 14 0.0001
820 INJURY ASSOCIATED WITH DEVICE 3 0.0001
821 HYPOAESTHESIA 22 0.0001
822 PNEUMONITIS 4 0.0001
823 RASH ERYTHEMATOUS 7 0.0001
824 LUNG NEOPLASM MALIGNANT 6 0.0001
825 INJECTION SITE WARMTH 3 0.0001
826 RIB FRACTURE 3 0.0001
827 RESPIRATORY DISTRESS 4 0.0001
828 SOMNOLENCE 29 0.0001
829 APHONIA 2 0.0001
830 RASH MACULAR 5 0.0001
831 HYPERKALAEMIA 5 0.0001
832 BLOOD TEST ABNORMAL 2 0.0001
833 SKIN EXFOLIATION 12 0.0001
834 DEVICE OCCLUSION 2 0.0001
835 HYPONATRAEMIA 8 0.0001
836 CEREBROVASCULAR ACCIDENT 24 0.0001
837 DIALYSIS 2 0.0001
838 SYSTEMIC LUPUS ERYTHEMATOSUS 5 0.0001
839 CARDIOGENIC SHOCK 2 0.0001
840 POOR QUALITY SLEEP 3 0.0001
841 BLOOD CREATINE PHOSPHOKINASE INCREASED 4 0.0001
842 ALTERED STATE OF CONSCIOUSNESS 3 0.0001
843 FAECES DISCOLOURED 3 0.0001
844 SEPTIC SHOCK 6 0.0001
845 BLOOD CREATININE INCREASED 9 0.0001
846 INJECTION SITE HAEMORRHAGE 11 0.0001
847 LIVER FUNCTION TEST ABNORMAL 4 0.0001
848 DRUG INEFFECTIVE 181 0.0001
849 APATHY 2 0.0001
850 INJECTION SITE ERYTHEMA 17 0.0001
851 ASCITES 4 0.0001
852 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
853 WHEEZING 8 0.0001
854 HAEMORRHAGE 14 0.0001
855 PANCREATITIS ACUTE 3 0.0001
856 BONE LOSS 2 0.0001
857 HALLUCINATION 10 0.0001
858 UNEVALUABLE EVENT 10 0.0001
859 ASPARTATE AMINOTRANSFERASE INCREASED 7 0.0001
860 INCORRECT DOSE ADMINISTERED 30 0.0001
861 SUICIDAL IDEATION 12 0.0001
862 INJECTION SITE RASH 4 0.0001
863 RENAL DISORDER 6 0.0001
864 DELUSION 2 0.0001
865 SWOLLEN TONGUE 4 0.0001
866 PRODUCT PRESCRIBING ERROR 3 0.0001
867 PRODUCT STORAGE ERROR 11 0.0001
868 MOBILITY DECREASED 9 0.0001
869 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 6 0.0001
870 HIP FRACTURE 4 0.0001
871 LACTIC ACIDOSIS 4 0.0001
872 PSORIATIC ARTHROPATHY 5 0.0001
873 SWELLING FACE 8 0.0001
874 INJECTION SITE URTICARIA 3 0.0001
875 ENCEPHALOPATHY 3 0.0001
876 GENERAL PHYSICAL HEALTH DETERIORATION 14 0.0001
877 INFUSION RELATED REACTION 8 0.0001
878 VISUAL ACUITY REDUCED 4 0.0001
879 AGEUSIA 3 0.0001
880 PNEUMONIA ASPIRATION 3 0.0001
881 COAGULOPATHY 2 0.0001
882 LEUKOPENIA 6 0.0001
883 GAIT INABILITY 4 0.0001
884 BLOOD UREA INCREASED 2 0.0001
885 DISEASE PROGRESSION 14 0.0001
886 PRODUCT QUALITY ISSUE 16 0.0001
887 INJECTION SITE SWELLING 9 0.0001
888 HEPATITIS 3 0.0001
889 THROMBOCYTOPENIA 13 0.0001
890 EXPOSURE VIA SKIN CONTACT 3 0.0001
891 NIGHTMARE 4 0.0001
892 DEVICE DISLOCATION 5 0.0001
893 MENTAL DISORDER 5 0.0001
894 JOINT STIFFNESS 3 0.0001
895 INTENTIONAL PRODUCT MISUSE 10 0.0001
896 AMENORRHOEA 2 0.0001
897 DEVICE MALFUNCTION 8 0.0001
898 DRUG INTERACTION 18 0.0001
899 FEAR 3 0.0001
900 WRONG TECHNIQUE IN DRUG USAGE PROCESS 4 0.0001
901 DEVICE DELIVERY SYSTEM ISSUE 3 0.0001
902 SKIN LESION 3 0.0001
903 ABNORMAL DREAMS 3 0.0001
904 ADVERSE EVENT 10 0.0001
905 BLOOD GLUCOSE ABNORMAL 2 0.0001
906 MENTAL STATUS CHANGES 3 0.0001
907 ARTHROPATHY 6 0.0001
908 BACTERIAL INFECTION 2 0.0001
909 INCORRECT DRUG ADMINISTRATION DURATION 3 0.0001
910 PRODUCT DOSE OMISSION IN ERROR 3 0.0001
911 INTERNATIONAL NORMALISED RATIO INCREASED 3 0.0001
912 HYPOGLYCAEMIA 5 0.0001
913 NEUTROPENIA 14 0.0001
914 HYPERSENSITIVITY 19 0.0001
915 LUNG DISORDER 5 0.0001
916 ABNORMAL BEHAVIOUR 4 0.0001
917 CARDIAC FAILURE 8 0.0001
918 EMOTIONAL DISTRESS 12 0.0001
919 ILL-DEFINED DISORDER 6 0.0001
920 BLINDNESS 4 0.0001
921 EPILEPSY 3 0.0001
922 NERVOUSNESS 5 0.0001
923 MUSCULOSKELETAL PAIN 5 0.0001
924 SPEECH DISORDER 5 0.0001
925 AGITATION 7 0.0001
926 WITHDRAWAL SYNDROME 4 0.0001
927 BRADYCARDIA 5 0.0001
928 VAGINAL HAEMORRHAGE 4 0.0001
929 PSORIASIS 12 0.0001
930 OSTEONECROSIS 3 0.0001
931 URINARY RETENTION 3 0.0001
932 ADVERSE DRUG REACTION 8 0.0001
933 APPLICATION SITE PRURITUS 2 0.0001
934 HAEMATURIA 3 0.0001
935 SKIN IRRITATION 4 0.0001
936 HYPOXIA 3 0.0001
937 BLADDER CANCER 5 0.0001
938 CARDIAC ARREST 7 0.0001
939 DISEASE RECURRENCE 4 0.0001
940 RENAL IMPAIRMENT 7 0.0001
941 DIABETIC KETOACIDOSIS 2 0.0001
942 IRRITABILITY 5 0.0001
943 CRYING 3 0.0001
944 ACCIDENTAL OVERDOSE 3 0.0001
945 ACNE 6 0.0001
946 ERECTILE DYSFUNCTION 2 0.0001
947 AMNESIA 5 0.0001
948 APPLICATION SITE ERYTHEMA 2 0.0001
949 DERMATITIS ATOPIC 4 0.0001
950 DEVICE DIFFICULT TO USE 5 0.0001
951 ABORTION SPONTANEOUS 3 0.0001
952 INJECTION SITE PRURITUS 5 0.0001
953 DEVICE BREAKAGE 3 0.0001
954 MULTIPLE SCLEROSIS RELAPSE 5 0.0001
955 TREATMENT FAILURE 6 0.0001
956 MEDICATION ERROR 4 0.0001
957 RHABDOMYOLYSIS 3 0.0001
958 OVERDOSE 15 0.0001
959 SEIZURE 8 0.0001
960 LIVER DISORDER 3 0.0001
961 THERAPEUTIC PRODUCT EFFECT DECREASED 3 0.0001
962 DEATH 57 0.0001
963 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
964 SUICIDE ATTEMPT 4 0.0001
965 DRUG DOSE OMISSION BY DEVICE 5 0.0001
966 RENAL CANCER 3 0.0001
967 PRODUCT DOSE OMISSION 4 0.0001
968 EXPIRED PRODUCT ADMINISTERED 2 0.0001
969 AGGRESSION 3 0.0001
970 NEOPLASM MALIGNANT 4 0.0001
971 DRUG EXPOSURE DURING PREGNANCY 2 0.0001
972 ACCIDENTAL EXPOSURE TO PRODUCT 6 0.0001
973 MATERNAL EXPOSURE DURING PREGNANCY 5 0.0001
974 SKIN BURNING SENSATION 4 0.0001
975 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
976 C-REACTIVE PROTEIN INCREASED 2 0.0001
977 PANCYTOPENIA 3 0.0001
978 DYSKINESIA 2 0.0000
979 MALIGNANT NEOPLASM PROGRESSION 5 0.0000
980 CARDIO-RESPIRATORY ARREST 2 0.0000
981 DRUG WITHDRAWAL SYNDROME 4 0.0000
982 DEVICE ISSUE 4 0.0000
983 NO ADVERSE EVENT 8 0.0000
984 DRUG DOSE OMISSION 7 0.0000
985 COMA 2 0.0000
986 DRUG EFFECT DECREASED 2 0.0000
987 TOXICITY TO VARIOUS AGENTS 6 0.0000
988 BREAST CANCER 3 0.0000
989 DRUG DEPENDENCE 4 0.0000
990 FOETAL EXPOSURE DURING PREGNANCY 2 0.0000